This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dion's Thursday ETF Winners and Losers

Stocks in this article: VXXTLTUUPFBTNORWCOPX

NEW YORK ( TheStreet) -- Welcome to Don Dion's "Daily ETF Winners and Losers." Be sure to stop by each day to find out which ETFs are gaining or losing.

Winners

iPath S&P 500 VIX Short Term Futures ETN (VXX) 9.1%

The markets are struggling to follow through on Wednesday's gains, but they are weighed down by weak jobless claims data and broad market jitters.

This scenario bodes well for ETNs that follow the fear-tracking VIX. VXX is witnessing its third day of upward action and is currently trading at June highs. iPath S&P 500 VIX Mid Term Futures ETN (VXZ) is gaining ground as well. The fund's jump is helping it test its 50-day moving average once again.

iShares Barclays 20+ Year Treasury Bond Fund (TLT) 2.0%

Long-term U.S. treasuries have seen a steep climb over the past week as the market's shaky action drives investors into defensive assets. With these gains, the fund is nearing 2010 highs.

Not surprisingly, the inverse-tracking ProShares UltraShort 20+ Year Treasury Bond ETF (TBT) is tumbling, suffering its eighth consecutive day of losses.

PowerShares DB U.S. Dollar Index Bullish Portfolio (UUP) 1.4%

In the same fashion as the TLT, the U.S. dollar is benefiting as investors steer clear of risky asset classes in an effort to seek shelter from the market's downward action. UUP's gains have pushed the fund back to its 50-day moving average.

Despite investor desire for protection, gold is seeing relatively unchanged action. Meanwhile, silver, palladium and platinum are seeing pronounced losses.

Losers

Global X Norway ETF (NORW) -8.1%

The economic issues facing Europe have once again fallen into focus leading a number of ETFs lower. Some of the funds leading the retreat include NORW, iShares MSCI Turkey Investable Market Index Fund (TUR) and iShares MSCI Sweden Index Fund (EWD).

This region of the globe must be approached with extreme caution.

First Trust NYSE Arca Biotech Index Fund (FBT) -7.6%

News of weak sales for its prostate cancer drug, Provenge, sent shares of closely watched biotechnology player Dendreon (DNDN) spiraling, dropping over 65%. This tumble is weighing heavily across the biotech sector, leading ETFs like FBT and iShares Nasdaq Biotechnology Index Fund (IBB) to suffer heavy losses.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs